Breast Cancer Patients Clinical Trials

10 recruiting

Breast Cancer Patients Trials at a Glance

18 actively recruiting trials for breast cancer patients are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Cairo, Brno, and Baltimore. Lead sponsors running breast cancer patients studies include Henan Cancer Hospital, Centre Hospitalier Universitaire Saint Pierre, and Cairo University.

Browse breast cancer patients trials by phase

Treatments under study

About Breast Cancer Patients Clinical Trials

Looking for clinical trials for Breast Cancer Patients? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Breast Cancer Patients trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Breast Cancer Patients clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Not Applicable

Cancer Survivors Program

Breast Cancer PatientsProstate Cancer Patients
Masaryk Memorial Cancer Institute200 enrolled1 locationNCT07253987
Recruiting
Not Applicable

Prevention of CIPN Using Compressive Therapy

CIPN in Adjuvant Breast Cancer Patients
Martina Lojova100 enrolled1 locationNCT06823440
Recruiting
Not Applicable

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

Breast Cancer Patients
Tuba Eryiğit30 enrolled1 locationNCT06964802
Recruiting
Phase 2

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

HER2-negative Breast Cancer Patients With Brain Metastases
Biostar Pharma, Inc.120 enrolled17 locationsNCT06764940
Recruiting

Breast Cancer BRAs Study (Breast Cancer Biomechanics of Radiotherapy And Surgery)

Breast Cancer Patients
Portsmouth Hospitals NHS Trust45 enrolled1 locationNCT07135960
Recruiting
Not Applicable

Rhomboid Intercostal Block With Sub-Serratus Plane Block Versus Erector Spinae Block

Breast Cancer Patients
Cairo University80 enrolled1 locationNCT07041762
Recruiting

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

Breast Cancer Patients
Henan Cancer Hospital104 enrolled1 locationNCT07037576
Recruiting
Not Applicable

Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation

Breast Cancer Patients
Henan Cancer Hospital26 enrolled1 locationNCT07037537
Recruiting
Not Applicable

Ultrasound-guided Multilevel Erectorspinae Plane Block Versus Thoracic Epidural Analgesia for Prevention of Post Mastectomy Pain Syndrome for Breast Cancer Patients

Breast Cancer PatientsUltrasoundMultilevel Erector Spinae Plane Block+3 more
National Cancer Institute, Egypt44 enrolled1 locationNCT06884852
Recruiting
Phase 2

Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer

Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)
Yonsei University141 enrolled1 locationNCT06837792
Recruiting
Phase 1Phase 2

Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury

To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients
Shandong Cancer Hospital and Institute24 enrolled1 locationNCT06847555
Recruiting
Not Applicable

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer Patients+4 more
Centre Hospitalier Universitaire Saint Pierre160 enrolled1 locationNCT06828640
Recruiting
Not Applicable

Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients

Chemotherapy Induced Peripheral NeuropathyBreast Cancer Patients
Riphah International University24 enrolled2 locationsNCT06737926
Recruiting

The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology

Prostate CancerBreast Cancer PatientsMelanoma Cancer+1 more
Leiden University Medical Center500 enrolled3 locationsNCT06685562
Recruiting

HYPO-BL: Breast Lymphoedema and Radiation Treatment Randomised Controlled Trial – Ultra versus Moderate Breast Hypofractionation Radiation Treatment

Breast CancerBreast Lymphoedema in Breast cancer patients receiving radiotherapy
Gosford Hospital200 enrolled1 locationACTRN12623001172695
Recruiting
Not Applicable

Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions

Breast Cancer PatientsHealth, Subjective
Norwegian Institute of Public Health390 enrolled1 locationNCT04480203
Recruiting
Phase 2Phase 3

A Randomized Trial Compared the Efficacy and Safety of Combined Use of Indocyanine Green Fluorescence and Methylene Blue Dye Versus Methylene Blue Dye alone for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Sentinel Lymph Node Biopsy in Breast Cancer Patients
Peking University People's Hospital Breast Cancer Center100 enrolled1 locationACTRN12612000109808
Recruiting

Inter-ethnic differences in tolerance of anti-cancer drugs in breast cancer patients

tolerance of adjuvant anthracycline-based chemotherapy in breast cancer patients
Sydney Cancer Centre120 enrolled1 locationACTRN12610000045011